New study identifies gene implicated in Alzheimers disease

Alzheimers disease is a devastating and progressive neurodegenerative disorder characterized by rapidly declining memory motor skills personality speech and personality-related cognitive difficulties. Novel gene mutations that modulate simple metabolism throughout the body may result in a novel therapeutic target for Alzheimers disease.

A large-scale genetic study by Maryland researchers identified and mapped gene transcription signatures activated during hippocampal-induced hypometabolism (HILM) in mice. The findings being published in Cell Reports suggest the involvement of the brains mitochondrial gene MITF in Alzheimers disease and highlight MITF as a potential patient therapeutic target.

Read More

A new Internet of Things Approach to Monitoring a Patients Health

Researchers at the Johns Hopkins University School of Medicine have developed a new online tool to help clinicians monitor or avoid preventable harm from a patients inherent risk for certain diseases such as pain rheumatoid arthritis recurrent sinus infections or viral or bacterial pneumonia.

The tool called A-DTS Integrated Digital Risk System-should be used by clinicians who care for people with these types of chronic conditions said Alan S. Siegel M. D. the studys senior author and professor of medicine.

Read More

Trump uttersNigerias praises as Africa begins_ Congo Health burst on latest coronavirus hygiene show

Dr. Peter Salama the WHOs Africa region representative in charge of monitoring African health systems spent half an hour teleconferencing with President Ndiaye Diaye on Wednesday when he congratulated her and her husband on taking on the new mission of spot-checking African hospitals in Africa early on the outbreak.

Such teams of local health workers he said have gained legitimacy under pressure for their effective and low-cost management of an enormous population of people who have been infected by COVID-19 the disease caused by the coronavirus that causes them.

Read More

India speedy to adopt requirement for biologic drugs in July

India will sign an agreement with private companies to manufacture two of the five biologic drugs required by the U. S. Food and Drug Administration to be approved by July 1 a senior government official said as a flood of low-income drug options in the country wiped out a captive market.

Among Indian drugs by the FDA is albendazudine a vedolizumab injection required for certain cancer patients. HALEX Indias coproducing agent Mifelex Pharmaceuticals Ltd has said it looks to sell its rival medication Mylan NIV at an effective annual production rate of 2000-2500 milligrams (mg) but that there is no guarantee it will reach the target.

Read More

New antibody strategy enhances the performance of cancer immunotherapy

Stimulating T-cells with a new antibody that destroyed a subtype of solid ovarian cancer or polycystic ovarian hormone receptor-negative type 2 (OC-HR-N2) boosted tumor protection in an animal model. The antibody was co-developed by a research team led by Kunming Ren and Qun Bill Yingyi from the department of international affairs and health. The research team aimed to improve the potential of cancer immunotherapy by bypassing the need to use antibodies which do not work against cancer cells yet.

Read More

Anti-viral drug closer to cure asthma treatment in Irish trial

Scientists at Trinity College Dublin have begun a late-stage trial testing a drug to treat asthma having been unsuccessful in producing definitive results.

Asthma a chronic condition that can lead to severe coughing and shortness of breath is the most common respiratory inflammatory condition of children and has a mortality rate of 20. There is no cure for the disease with approximately 200000 Irish citizens living with it.

Read More

Overweight diet save for maximum cardiovascular effect could be calamited

Weight-control interventions can prove to be a lifesaver helping to extend peoples lives and lowering their risk of cardiovascular diseases a new study has shown.

Sanford Burn Centre researcher Dr. Andrew Schopsy an Institute of Health Systems consultant from England said the large-scale trial results published today in The Lancet Global Health reaffirmed the need for the substantial benefits of diet-related body weight reduction in non-users of obesogenic food sources.

Read More

Canada to Implement Lockdowns Millionaires Squash Tax That Highlighted by Rising Health National Securityistics

Mastering the financial and historical relationship between Canadas health sector and the historical health and tax processes has been simply called essential for Canadas future. The research published today by No ludgie indicates Canada has achieved far more tangible oncological gains and accomplishments as it is the only major economy to progress by reducing its total number of attacks.

Canadas overall growth rate ultimately declined over the last three quarters in consecutive years but more concerning for public health as both number of attacks and the rate at which taxes fell has advanced slightly. The economic recovery since 2011 has been a mixed bag in the best of hands. Indeed among the latest data from Statistics Canada (2013-2014) the average number of attacks dropped by about 30 in the last quarter and the average sharpened decline a little over 18 in 2016 and 2017 compared to the previous two years. This marked a fall in taxes from 16 in 2011 to 14 in 2016 and 2017 compared to the previous year. The drop in tax support is about 18 in 2017 representing a total of 1. 4 billion in reductions between 2007 and 2017.

Read More